# =============================================================================
# Eli Lilly and Company — Central Assumptions File
# =============================================================================
# Auto-generated by run_top10.py
#Params: ELI LILLY (Feb 2026): FY ends Dec. Revenue $65B 2025 (+45% YoY). β=0.50 (defensive pharma). OpM 40%. Mounjaro (diabetes) + Zepbound (obesity) = two blockbusters. GLP-1 category could be $150B+ TAM by 2030. Patent cliff risk in late 2030s. R&D 20% of revenue.
# =============================================================================

company:
  name: Eli Lilly and Company
  ticker: LLY
  currency: USD
  fiscal_year_end: December
  description: "ELI LILLY (Feb 2026): FY ends Dec. Revenue $65B 2025 (+45% YoY). \u03B2=0.50 (defensive pharma). OpM 40%.\
    \ Mounjaro (diabetes) + Zepbound (obesity) = two blockbusters. GLP-1 category could be $150B+ TAM by 2030. Patent cliff\
    \ risk in late 2030s. R&D 20% of revenue."
tax:
  effective_rate: 0.15
  marginal_rate: 0.21
cost_of_capital:
  risk_free_rate: 0.045
  equity_risk_premium: 0.05
  beta: 0.5
  country_risk_premium: 0.0
  pre_tax_cost_of_debt: 0.04
  target_debt_to_capital: 0.35
projection:
  explicit_years: 10
  terminal_growth_rate: 0.025
revenue:
  base_year_revenue: null
  near_term_growth_rates:
  - 0.25
  - 0.22
  - 0.18
  - 0.12
  - 0.08
  long_term_growth_rate: 0.04
margins:
  gross_margin: 0.82
  operating_margin: 0.4
  rd_to_revenue: 0.2
  sga_to_revenue: 0.2
capital_intensity:
  capex_to_revenue: 0.1
  depreciation_to_revenue: 0.05
  nwc_to_revenue: 0.15
working_capital_days:
  dso: 55
  dio: 170
  dpo: 70
roic:
  capitalize_rd: false
  rd_amortization_years: 5
sensitivity:
  wacc_range:
  - 0.05
  - 0.055
  - 0.06
  - 0.065
  - 0.07
  - 0.075
  - 0.08
  - 0.085
  - 0.09
  terminal_growth_range:
  - 0.015
  - 0.02
  - 0.025
  - 0.03
  - 0.035
market_data:
  price_start_date: '2000-01-01'
  benchmark_ticker: ^GSPC
sec:
  cik: 0000059478
  user_agent: StockValuation research@example.com
  base_url: https://data.sec.gov/api/xbrl/companyfacts
  annual_forms:
  - 10-K
  - 10-K/A
  years_to_keep: 10
